Drug resistance missense mutations in cancer are subject to evolutionary constraints.
Several tumour types are sensitive to deactivation of just one or very few genes that are constantly active in the cancer cells, a phenomenon that is termed 'oncogene addiction'. Drugs that target the products of those oncogenes can yield a temporary relief, and even complete remission. Un...
Guardado en:
Autor principal: | Ran Friedman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93a48e6a78cf47b1820bcbc58988b719 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Decoding disease-causing mechanisms of missense mutations from supramolecular structures
por: Atsushi Hijikata, et al.
Publicado: (2017) -
A novel missense mutation in the HSF4 gene of giant pandas with senile congenital cataracts
por: Yuyan You, et al.
Publicado: (2021) -
Functional analyses of a novel missense and other mutations of the vitamin D receptor in association with alopecia
por: Mayuko Tamura, et al.
Publicado: (2017) -
Missense mutation of VKORC1 leads to medial arterial calcification in rats
por: Arnaud Michaux, et al.
Publicado: (2018) -
Male hypogonadism caused by a homozygous missense mutation of the LHB gene
por: Jie Chen, et al.
Publicado: (2021)